Details for 2017857601
Up to date per 01.04.2026
Actions
Details for 2017857601
Granted/Registered
European Patent
07.08.2019 A
09.02.2022 B1
30.09.2016
US
201662402938 P
A61K 9/14 20060101AFI20200422BHEP
Owner
Mati Therapeutics Inc.4317 Dunning Lane Austin, TX 78746US
Representative
Authorized Recipients
Dr. Markus Zollerc/o HGF Europe LLP, Rudolfskai 485020 SalzburgAT
Inventor
UTKHEDE, Deepank201-4475 Wayburne Drive Burnaby, British Columbia V5G 4X4CA
JONES, Catherine201-4475 Wayburne Drive Burnaby, British Columbia V5G 4X4CA
WISEMAN, David201-4475 Wayburne Drive Burnaby, British Columbia V5G 4X4CA
Information about Fees